| 000 | 01209 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516175435.0 | ||
| 264 | 0 | _c20160425 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a2164-554X | ||
| 024 | 7 |
_a10.4161/hv.26890 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRydén, Anna K E | |
| 245 | 0 | 0 |
_aNon-antigenic and antigenic interventions in type 1 diabetes. _h[electronic resource] |
| 260 |
_bHuman vaccines & immunotherapeutics _c2014 |
||
| 300 |
_a838-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCD3 Complex _ximmunology |
| 650 | 0 | 4 |
_aChaperonin 60 _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xtherapy |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aInsulin _xtherapeutic use |
| 650 | 0 | 4 |
_aPeptide Fragments _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWesley, Johnna D | |
| 700 | 1 | _aCoppieters, Ken T | |
| 700 | 1 | _aVon Herrath, Matthias G | |
| 773 | 0 |
_tHuman vaccines & immunotherapeutics _gvol. 10 _gno. 4 _gp. 838-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/hv.26890 _zAvailable from publisher's website |
| 999 |
_c23207278 _d23207278 |
||